Pfizer Agrees to Pay Nearly 60M to Resolve False Claims …
1 day ago · Note: View the settlement here.. Pharmaceutical company Pfizer Inc. (Pfizer), on behalf of its wholly-owned subsidiary Biohaven Pharmaceutical Holding Company Ltd. (Biohaven), has agreed to pay $59,746,277 to resolve allegations that, prior to Pfizer’s acquisition of the company, Biohaven knowingly caused the submission of false claims to Medicare and other federal health care programs by ...
Pfizer’s BRAFTOVI® Combination Regimen Demonstrates …
1 day ago · NEW YORK, January 25, 2025--Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed ...
Pfizer to pay nearly $60M over kickbacks for migraine drug once ...
1 day ago · Pfizer ended the Nurtec speaker programs after paying $11.5 billion to buy Biohaven. Read On The Fox Business App "Patients deserve to know that their doctor is prescribing medications based on ...
Newsroom - Pfizer
Pfizer Inc. today introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S. Our mission to make breakthroughs that change patients’ …
Pfizer’s BRAFTOVI® Combination Regimen Demonstrates …
1 day ago · Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial show objective response rate of 61% with Pfizer’s BRAFTOVI combination regimen compared to 40% with investigator’s choice of chemotherapy, representing a doubling of the odds of achieving an objective response BRAFTOVI combination regimen is the first and only targeted therapy approved by the U.S ...
Pfizer Inc. (PFE) Latest Stock News & Headlines - Yahoo Finance
Get the latest Pfizer Inc. (PFE) stock news and headlines to help you in your trading and investing decisions.
Press Releases - Pfizer
Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
CDC identifies possible safety issue with Pfizer’s updated ... - CNN
Jan 13, 2023 · The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech but that it is unlikely to...
Exclusive: Pfizer explores sale of hospital drugs unit, sources say
Nov 12, 2024 · Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to...
Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent
Jan 14, 2025 · On the cost side, Pfizer achieved $4 billion in savings and announced an additional $1.5 billion in margin improvements. In R&D, leadership changed for the first time in 15 years,
- Some results have been removed